704 patents currently held
83 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2 more records may belong here and await a decision; they are not counted.
The next term ends in Jun 2027. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
25
Ending by 2030
Jun 2027
Next term end
521
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Feb 2037 · High confidence
Also notable
Ends Jan 2034 · High confidence
Also notable
Ends no later than Mar 2035 · Medium confidence
Also notable
Ends Nov 2031 · High confidence
Also notable
Ends Sep 2038 · High confidence
Also notable
Ends Nov 2037 · High confidence
Also notable
Ends Jul 2033 · High confidence
Also notable
Ends Sep 2036 · High confidence
Methods, Devices, and Manufacture of the Devices for Musculoskeletal Reconstructive Surgery
US 11,628,001
Cited by 167 later US patents, top 1% of utility patents granted in 2023 in our data. Protection runs to 2037.
System and Method for Efficient Use of Network Bandwidth Based on User Profiles and Other Data
US 10,178,580
Cited by 64 later US patents, top 5% of utility patents granted in 2019 in our data, and renewed at 2 of 3 maintenance windows. Protection runs to 2034.
Prebiotic Formulations
US 10,624,934
Cited by 34 later US patents, top 5% of utility patents granted in 2020 in our data. Protection runs to 2035. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Predictive Network System and Method
US 9,680,766
Cited by 62 later US patents, top 5% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2031. A terminal disclaimer caps this term to an earlier patent's.
Systems and Methods for Predictive Heart Valve Simulation
US 11,382,694
Cited by 14 later US patents, top 10% of utility patents granted in 2022 in our data. Protection runs to 2038.
Cyclic Cell Penetrating Peptides Comprising Beta-Hairpin Motifs and Methods of Making and Using Thereof
US 11,352,394
Cited by 16 later US patents, top 10% of utility patents granted in 2022 in our data. Protection runs to 2037.
Intrathecal Delivery of Recombinant Adeno-Associated Virus 9
US 11,040,116
Cited by 7 later US patents, top 25% of utility patents granted in 2021 in our data. Protection runs to 2033.
Contact Lens Comprising a Lenticular in a Superior Portion of the Contact Lens
US 11,022,816
Cited by 12 later US patents, top 25% of utility patents granted in 2021 in our data. Protection runs to 2036. A terminal disclaimer caps this term to an earlier patent's.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 11 fees due Nov 21 to 30, 2026 · next Nov 21
- 12 fees due Dec 2 to 27, 2026 · next Dec 2
- 5 fees due Jan 9 to 30, 2027 · next Jan 9
- 13 fees due Feb 6 to 28, 2027 · next Feb 6
- 9 fees due Mar 10 to 29, 2027 · next Mar 10
- 21 fees due Apr 3 to 30, 2027 · next Apr 3
- 13 fees due May 3 to 28, 2027 · next May 3
- 21 fees due Jun 10 to 29, 2027 · next Jun 10
- 11 fees due Jul 2 to 30, 2027 · next Jul 2
- 7 fees due Aug 4 to 23, 2027 · next Aug 4
- 11 fees due Sep 1 to 30, 2027 · next Sep 1
- 16 fees due Oct 7 to 30, 2027 · next Oct 7
- 12 fees due Nov 7 to 19, 2027 · next Nov 7
Recent changes
- Nov 9Assignment recorded on US 12,788,361: Liu, Jun and 1 other to Ohio State Innovation Foundation Recorded Nov 9, 2026, executed Oct 9, 2026. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76685, frame 239.
- Nov 6Assignment recorded on 1 record: Zhu, Hua and 1 other to Ohio State Innovation Foundation Recorded Nov 6, 2026, executed Sep 1, 2023. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76659, frame 125.
- 34 of the patents on this record were granted since Aug 23, 2026
- 2 terms have ended since Aug 23, 2026
- Nov 19 US 7,691,396 Chimeric Peptides Comprising HER-2 B-Cell Epitopes and Measles Virus Fusion Protein T-Cell Epitopes · term ended
- Aug 27 US 7,705,996 Methods and Systems for Ultra-Precise Measurement and Control of Object Motion in Six Degrees of Freedom by Projection and Measurement of Interference Fringes · term ended
What they patent
The largest of its 521 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,541,460 | PDK-1/AKT Signaling Inhibitors In force · Medium confidence | In force | Medium confidence | |
| US 7,767,191 | Combustion Looping Using Composite Oxygen Carriers In force · High confidence | In force | High confidence | |
| US 10,143,658 | Multistage Delivery of Active Agents In force · High confidence | In force | High confidence | |
| US 7,745,132 | Prognostic Indicators of Canine Lymphoid Neoplasia Using Tumor-Derived Plasma DNA In force (reinstated) · High confidence | In force (reinstated) | High confidence | |
| US 7,893,616 | Process to Determine Enzyme Activity In force · High confidence | In force | High confidence | |
| US 8,057,653 | Carbon Dioxide Sensor In force · High confidence | In force | High confidence | |
| US 7,694,547 | Robust High Temperature Composite and Co Sensor Made from Such Composite In force · High confidence | In force | High confidence | |
| US 8,741,944 | Anti-Infective Agents Against Intracellular Pathogens In force · High confidence | In force | High confidence | |
| US 10,030,273 | Microrna Expression in Human Peripheral Blood Microvesicles and Uses Thereof In force · High confidence | In force | High confidence | |
| US 7,745,820 | Negative Differential Resistance Polymer Devices and Circuits Incorporating Same In force · High confidence | In force | High confidence |
Also on record, not counted in the 704: 83 patents in force now held by others · 84 patents ended · 623 applications pending · 263 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.